Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Return on Capital Employed (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Return on Capital Employed data on record, last reported at 0.99% in Q3 2025.

  • For Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.99%; the TTM value through Sep 2025 reached 0.99%, changed N/A, while the annual FY2024 figure was 0.22%, 54.0% up from the prior year.
  • Return on Capital Employed reached 0.99% in Q3 2025 per GOSS's latest filing, down from 0.7% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.21% in Q4 2024 and bottomed at 1.27% in Q2 2023.
  • Average Return on Capital Employed over 4 years is 0.71%, with a median of 0.78% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: soared 98bps in 2024, then plummeted -41bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 0.88% in 2022, then rose by 25bps to 0.66% in 2023, then surged by 68bps to 0.21% in 2024, then crashed by -375bps to 0.99% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.99% in Q3 2025, 0.7% in Q2 2025, and 0.22% in Q1 2025.